Peptide Therapy for Inflammation: A New Solution BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Erectile Dysfunction: What the Evidence Shows and Practical Considerations